InsiderTrades.com logo

ALLO Insider Trading

Insider Ownership Percentage: 13.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $586,720.72

Allogene Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allogene Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allogene Therapeutics Share Price & Price History

Current Price: $2.07
Price Change: ▼ Price Decrease of -0.15 (-6.76%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for ALLO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Allogene Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2026Benjamin Machinas BeneskiSVPSell4,835$2.47$11,942.45198,205View SEC Filing Icon  
3/16/2026David D. ChangCEOSell47,763$2.47$117,974.615,150,599View SEC Filing Icon  
3/2/2026Benjamin Machinas BeneskiSVPSell7,132$2.60$18,543.20203,040View SEC Filing Icon  
2/2/2026Annie YoshiyamaSVPSell4,167$1.72$7,167.24130,322View SEC Filing Icon  
2/2/2026Benjamin Machinas BeneskiSVPSell7,549$1.73$13,059.77210,172View SEC Filing Icon  
2/2/2026David D. ChangCEOSell95,269$1.80$171,484.205,185,862View SEC Filing Icon  
2/2/2026Earl Martin DouglasSVPSell22,900$1.76$40,304.00564,948View SEC Filing Icon  
2/2/2026Geoffrey M. ParkerCFOSell24,001$1.76$42,241.761,252,795View SEC Filing Icon  
2/2/2026Zachary RobertsEVPSell35,700$1.77$63,189.00581,166View SEC Filing Icon  
1/21/2026Zachary RobertsEVPSell26,269$1.56$40,979.64616,866View SEC Filing Icon  
10/21/2025Geoffrey M. ParkerCFOSell36,744$1.26$46,297.441,276,796View SEC Filing Icon  
4/21/2025Annie YoshiyamaSVPSell9,601$1.41$13,537.41130,663View SEC Filing Icon  
3/14/2025Benjamin Machinas BeneskiSVPSell5,488$1.98$10,866.24218,507View SEC Filing Icon  
3/14/2025David D. ChangCEOSell46,668$1.96$91,469.285,276,569View SEC Filing Icon  
2/3/2025Earl Martin DouglasSVPSell6,404$1.71$10,950.84587,848View SEC Filing Icon  
2/3/2025Geoffrey M. ParkerCFOSell4,361$1.73$7,544.531,301,540View SEC Filing Icon  
2/3/2025Timothy L MooreInsiderSell14,746$1.71$25,215.66250,713View SEC Filing Icon  
1/21/2025Zachary RobertsEVPSell27,199$1.78$48,414.22488,054View SEC Filing Icon  
12/9/2024Deborah M MessemerDirectorSell9,136$2.18$19,916.48157,629View SEC Filing Icon  
12/5/2024Franz B. HumerDirectorSell9,221$2.16$19,917.36307,507View SEC Filing Icon  
5/30/2024Franz B. HumerDirectorSell11,200$2.34$26,208.00255,253View SEC Filing Icon  
5/16/2024Arie BelldegrunDirectorBuy1,724,137$2.90$4,999,997.301,724,137View SEC Filing Icon  
1/30/2024Geoffrey M. ParkerCFOBuy190$3.60$684.00819,590View SEC Filing Icon  
12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.0062,456View SEC Filing Icon  
8/7/2023Stephen MayoDirectorSell10,000$4.29$42,900.0025,328View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Allogene Therapeutics (NASDAQ:ALLO)

83.63% of Allogene Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALLO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Allogene Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC148,136$0.20M0.0%+57.5%0.061%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd44,334$61K0.0%+84.4%0.020%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC42,351$58K0.0%+55.9%0.019%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.609,807$0.84M0.0%+16.1%0.271%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV29,512$40K0.0%+23.0%0.013%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd476,307$0.65M0.0%-38.5%0.212%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management192,731$0.26M0.0%-63.4%0.086%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC176,178$0.24M0.1%+116.8%0.078%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd274,416$0.38M0.0%+15.3%0.122%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,841,307$2.52M0.0%-45.7%0.819%Search for SEC Filing on Google Icon
2/18/2026Man Group plc526,106$0.72M0.0%+86.5%0.234%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC1,429,247$1.96M0.0%-22.9%0.636%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD3,209,275$4.40M0.0%-12.7%1.428%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.40,041$55K0.0%+83.3%0.018%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors53,101$73K0.0%+237.9%0.024%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada48,794$67K0.0%-95.6%0.022%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.148,671$0.20M0.0%-24.7%0.066%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC104,656$0.14M0.0%-61.0%0.047%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC642,687$0.88M0.0%+7.3%0.286%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP285,561$0.39M0.0%N/A0.127%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co50,951$69K0.0%+28.2%0.023%Search for SEC Filing on Google Icon
2/13/2026Kalehua Capital Management LLC2,546,129$3.49M3.2%N/A1.133%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC28,927$38K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC46,778$64K0.0%-66.6%0.021%Search for SEC Filing on Google Icon
2/13/2026OpenArc Corporate Advisory LLC162,984$0.22M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,355,809$1.86M0.0%+16.4%0.603%Search for SEC Filing on Google Icon
2/13/2026State Street Corp2,761,400$3.78M0.0%+0.2%1.229%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC435,267$0.60M0.0%+15.7%0.194%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN200,276$0.27M0.0%+38.3%0.089%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP72,751$99K0.0%-45.1%0.032%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC34,823$48K0.0%-39.2%0.015%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC2,187,084$3M0.0%-24.4%0.973%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP957,816$1.31M0.0%-54.2%0.426%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP4,963,756$6.80M1.5%+66.5%2.209%Search for SEC Filing on Google Icon
2/11/2026Primecap Management Co. CA8,139,840$11.15M0.0%+15.0%3.622%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG131,086$0.18M0.0%-6.9%0.058%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC97,909$0.13M0.0%-79.0%0.044%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC170,750$0.23M0.0%-3.8%0.076%Search for SEC Filing on Google Icon
2/11/2026Harold Davidson & Associates Inc.194,753$0.27M0.1%-34.1%0.087%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.2,289,458$3.14M0.0%+90.2%1.019%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC86,637$0.12M0.0%+20.5%0.039%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC3,932,910$5.39M0.0%+2.6%1.750%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP613,998$0.84M0.1%+235.7%0.273%Search for SEC Filing on Google Icon
2/5/2026Navalign LLC49,398$68K0.0%-17.5%0.022%Search for SEC Filing on Google Icon
1/30/2026R Squared Ltd86,215$0.12M0.1%+40.5%0.038%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC38,849$51K0.0%N/A0.017%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc2,086,332$2.86M0.0%+31.9%0.928%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.404%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd24,047$30K0.0%+5,267.6%0.011%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co39,730$50K0.0%+27.3%0.018%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd774,203$0.96M0.0%+2,687.7%0.345%Search for SEC Filing on Google Icon
11/17/2025Scientech Research LLC26,635$33K0.0%N/A0.012%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV23,998$30K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC3,390,026$4.20M0.0%+125.6%1.508%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.164,780$0.20M0.0%-8.2%0.073%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE974,320$1.21M0.0%-1.3%0.434%Search for SEC Filing on Google Icon
11/14/2025Zacks Investment Management526,132$0.65M0.0%+2.7%0.234%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP3,383,644$4.20M0.0%+109.7%1.506%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC250,000$0.31M0.0%N/A0.111%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC268,044$0.33M0.0%+1,383.7%0.119%Search for SEC Filing on Google Icon
11/13/2025Lynx1 Capital Management LP546,119$0.68M0.1%-95.1%0.243%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG3,571,157$4.43M0.0%+75.1%1.589%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets894,314$1.11M0.0%+1.7%0.398%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.21,844$27K0.0%+11,159.8%0.010%Search for SEC Filing on Google Icon
11/13/2025Dynamic Technology Lab Private Ltd39,677$50K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC598,997$0.74M0.0%-7.2%0.267%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP2,090,753$2.59M0.0%-23.6%0.930%Search for SEC Filing on Google Icon
11/12/2025R Squared Ltd61,373$76K0.0%+88.8%0.027%Search for SEC Filing on Google Icon
11/12/2025Primecap Management Co. CA7,079,308$8.78M0.0%+23.8%3.150%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC71,895$89K0.0%-27.1%0.032%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc414,074$0.51M0.0%-24.1%0.184%Search for SEC Filing on Google Icon
11/10/2025Patient Square Capital LP2,981,396$3.70M1.0%+13.1%1.327%Search for SEC Filing on Google Icon
11/7/2025Harold Davidson & Associates Inc.295,432$0.37M0.2%+118.5%0.133%Search for SEC Filing on Google Icon
11/7/2025Levin Capital Strategies L.P.52,500$65K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP182,879$0.23M0.0%-62.8%0.082%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.9,020,770$11.19M0.0%+9.2%4.066%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.410%Search for SEC Filing on Google Icon
11/7/2025Aberdeen Group plc1,582,265$1.96M0.0%+82.4%0.713%Search for SEC Filing on Google Icon
11/5/2025Moloney Securities Asset Management LLC514,000$0.64M0.1%+92.1%0.232%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC21,645$27K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/3/2025Coastal Bridge Advisors LLC21,789$27K0.0%-90.1%0.010%Search for SEC Filing on Google Icon
11/3/2025AustralianSuper Pty Ltd382,141$0.47M0.0%N/A0.170%Search for SEC Filing on Google Icon
10/31/2025Vanguard Personalized Indexing Management LLC85,720$0.11M0.0%+19.6%0.039%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC52,092$70K0.0%+178.0%0.023%Search for SEC Filing on Google Icon
10/15/2025CWM LLC64,332$80K0.0%+665.3%0.029%Search for SEC Filing on Google Icon
10/15/2025Vontobel Holding Ltd.62,080$77K0.0%+82.6%0.028%Search for SEC Filing on Google Icon
10/14/2025Brighton Jones LLC25,168$31K0.0%+81.6%0.011%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC26,852$33K0.0%-36.9%0.012%Search for SEC Filing on Google Icon
8/15/2025CANADA LIFE ASSURANCE Co31,211$35K0.0%+142.0%0.014%Search for SEC Filing on Google Icon
8/15/2025Man Group plc274,684$0.31M0.0%+47.6%0.126%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP32,465$37K0.0%N/A0.015%Search for SEC Filing on Google Icon
8/15/2025Brevan Howard Capital Management LP81,843$92K0.0%-66.7%0.037%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE987,495$1.12M0.0%+4.1%0.451%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC412,630$0.47M0.0%-63.0%0.189%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.179,576$0.20M0.0%-37.2%0.082%Search for SEC Filing on Google Icon
8/14/2025Cerity Partners LLC400,267$0.45M0.0%+5.2%0.183%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.396,512$0.45M0.0%+39.0%0.181%Search for SEC Filing on Google Icon
8/13/2025Virtus Investment Advisers LLC67,166$76K0.0%-17.4%0.031%Search for SEC Filing on Google Icon
8/13/2025Quadrature Capital Ltd44,050$50K0.0%+29.6%0.020%Search for SEC Filing on Google Icon
8/12/2025Foresite Capital Management VI LLC2,875,357$3.25M1.8%-16.6%1.315%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Allogene Therapeutics logo
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Read More on Allogene Therapeutics

Today's Range

Now: $2.07
Low: $2.06
High: $2.26

50 Day Range

MA: $2.01
Low: $1.45
High: $2.78

52 Week Range

Now: $2.07
Low: $0.86
High: $2.80

Volume

20,746,519 shs

Average Volume

4,922,762 shs

Market Capitalization

$504.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Allogene Therapeutics?

Allogene Therapeutics' top insider shareholders include:
  1. David D Chang (CEO)
  2. Arie Belldegrun (Director)
  3. Geoffrey M Parker (CFO)
  4. Zachary Roberts (EVP)
  5. Earl Martin Douglas (SVP)
  6. Franz B Humer (Director)
  7. Timothy L Moore (Insider)
  8. Benjamin Machinas Beneski (SVP)
  9. Deborah M Messemer (Director)
  10. Annie Yoshiyama (SVP)
Learn More about top insider investors at Allogene Therapeutics.

Who are the major institutional investors of Allogene Therapeutics?

Allogene Therapeutics' top institutional shareholders include:
  1. Primecap Management Co. CA — 3.62%
  2. Patient Square Capital LP — 2.21%
  3. Geode Capital Management LLC — 1.75%
  4. Price T Rowe Associates Inc. MD — 1.43%
  5. State Street Corp — 1.23%
  6. Kalehua Capital Management LLC — 1.13%
Learn More about top institutional investors of Allogene Therapeutics stock.

Which institutional investors are selling Allogene Therapeutics stock?

During the previous quarter, ALLO stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Dimensional Fund Advisors LP
  3. Royal Bank of Canada
  4. Renaissance Technologies LLC
  5. Price T Rowe Associates Inc. MD
  6. AQR Capital Management LLC
  7. Cerity Partners LLC
  8. Zacks Investment Management
Within the previous year, company insiders that have sold Allogene Therapeutics company stock include:
  1. David D Chang (CEO)
  2. Arie Belldegrun (Director)
  3. Geoffrey M Parker (CFO)
  4. Zachary Roberts (EVP)
  5. Earl Martin Douglas (SVP)
  6. Franz B Humer (Director)
Learn More investors selling Allogene Therapeutics stock.

Which institutional investors are buying Allogene Therapeutics stock?

During the previous quarter, ALLO stock was acquired by institutional investors including:
  1. Kalehua Capital Management LLC
  2. Patient Square Capital LP
  3. Goldman Sachs Group Inc.
  4. Primecap Management Co. CA
  5. Aberdeen Group plc
  6. GSA Capital Partners LLP
  7. Marshall Wace LLP
  8. Man Group plc